Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foster versus beclomethasone, formoterol, and placebo after allergen challenge in allergic asthma
NL-OMON32042Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of beclometasone dipropionate + formoterol, beclomethasone dipropionate and formoterol in allergic asthma (4 arms), sponsored by Leiden University Medical Center. Primary endpoint: Late asthmatic response. Started Jun 2009; status: active, not recruiting.
02
Drugs
beclometasone dipropionate + formoterolbeclomethasone dipropionateformoterol
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NL-OMON32042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32042.